Southern California Overdose & Addiction Statistics

By SoCal Addiction Centers Editorial Team | Last reviewed: | 12 min read Clinically Reviewed

Key Takeaways

  • California recorded more than 11,000 drug overdose deaths in 2023, per the CDPH Overdose Surveillance Dashboard. Fentanyl was involved in over 70% of those deaths.
  • Los Angeles County recorded more than 3,000 accidental drug overdose deaths in 2022 per LA County Department of Public Health surveillance — the highest raw county count in the United States. Fentanyl was involved in roughly 70% of LA County overdose mortality.
  • All six SoCal counties show fentanyl-dominant patterns following an East-Coast-to-West-Coast diffusion that became operationally clear in California around 2019–2020 and peaked through 2022–2023.
  • Methamphetamine is the second-most-prevalent substance in SoCal overdose mortality, frequently in combination with fentanyl. Polydrug deaths (multiple substances detected) now represent a majority of California drug-related fatalities.
  • Racial disparities are substantial: overdose mortality rates among Black Californians are higher than among white Californians across multiple measures. American Indian / Alaska Native Californians also show elevated rates.
  • Most recent data carries inherent lag: California and county overdose figures are typically published as “provisional” data 6–12 months after the reporting year, with final data following another 6–12 months later. 2024 and 2025 figures will shift as underlying records finalize.
  • Policy responses tied to the statistics include Narcan availability expansion (statewide standing order, free community distribution), fentanyl test strip legalization (California legislation effective 2024), DMC-ODS expansion, and continued CalAIM integration of behavioral health services.

California overdose landscape — the data we have

California’s overdose crisis tracks the national arc with state-specific features. The 2015–2020 period saw rising overdose deaths primarily from prescription opioids and heroin. The 2019–2023 period saw a dramatic shift as illicitly-manufactured fentanyl replaced much of the heroin supply, producing rapid and continuing increases in overdose mortality. The most recent CDPH-reported data places California among the U.S. states most affected by fentanyl-era overdose mortality in absolute terms, though per-capita rates vary by state and methodology.

This page summarizes the current California and SoCal-specific overdose data as reported by the California Department of Public Health and the six SoCal county public health agencies. Data is drawn from state-published surveillance dashboards and county-level reports available as of our review. Specific figures represent the most-recent-available published data and may be updated as underlying records finalize; readers seeking current data should check the source dashboards directly.

Statewide California overdose data

The CDPH Overdose Surveillance Dashboard is California’s primary public overdose-mortality data source. The dashboard publishes statewide and county-level data on drug-overdose deaths, fentanyl involvement, demographic distributions, and year-over-year trends.

Statewide figures for 2023 (most recent year with finalized data at review):

  • Total drug overdose deaths in California: over 11,000 — a slight decrease from 2022’s near-peak figure after several years of rapid increase
  • Fentanyl involvement: more than 70% of statewide overdose deaths involved fentanyl
  • Methamphetamine involvement: approximately 50% of overdose deaths involved methamphetamine, frequently in combination with fentanyl
  • Prescription opioid involvement: decreased significantly from 2015–2018 peak as supply shifted to illicit fentanyl
  • Cocaine involvement: approximately 20-25%, often in combination with fentanyl
  • Polydrug deaths: more than 60% of overdose deaths involve multiple substances

Trend trajectory: California overdose deaths increased sharply from 2019 through 2022, then showed early signs of stabilization or modest decrease through 2023 in some measures. Whether this represents a meaningful inflection point or data noise remains an empirical question being tracked through 2024–2025 reporting cycles.

Provisional vs final data: the CDPH dashboard distinguishes between provisional (preliminary) and final data. 2024 figures are currently provisional; final 2024 figures will publish in 2026 after underlying death-certificate and toxicology records complete. 2025 figures are not yet available.

Los Angeles County — the largest SoCal jurisdiction

Los Angeles County is California’s most populous county and has the highest absolute overdose death count in the United States. The LA County Department of Public Health Substance Abuse Prevention and Control (SAPC) publishes an Overdose Surveillance Dashboard with county-specific detail.

LA County figures (most recent year with finalized data at review — 2022 for final data):

  • Accidental drug overdose deaths in 2022: approximately 3,137 — the highest raw county count in the United States
  • Fentanyl involvement: approximately 71% of LA County overdose deaths
  • Rapid year-over-year increase: LA County overdose deaths approximately doubled between 2018 and 2022, driven primarily by fentanyl transition

Geographic concentration within LA County: overdose mortality is not evenly distributed across LA’s 4,750 square miles. Service Planning Areas with higher mortality rates include SPA 6 (South LA), SPA 4 (Metro LA including Downtown LA and Skid Row), and SPA 8 (South Bay coastal). Specific geographic concentration patterns track unhoused population density, poverty, and historical SUD service coverage gaps. See our Skid Row Addiction Services exploit page for the Skid Row / DTLA-specific context.

Demographic patterns in LA County:

  • Racial disparities: Black Angelenos experience overdose mortality at rates higher than the county-wide average
  • Age: the 30–55 age range shows the highest overdose mortality counts
  • Gender: male deaths exceed female deaths approximately 3:1

Orange County

The OC Health Care Agency publishes overdose surveillance data for Orange County. Relevant features of OC overdose data:

  • Absolute counts lower than LA given smaller population (approximately 3.2 million vs LA’s 10 million)
  • Fentanyl involvement consistent with statewide pattern — approximately 70% of OC overdose deaths involve fentanyl
  • Methamphetamine co-involvement — substantial portion of OC overdose deaths involve methamphetamine, often in combination with fentanyl

OC’s overdose data is integrated with the county’s broader behavioral health reporting through OC Behavioral Health Services.

San Diego County

San Diego County Health and Human Services Agency and the San Diego Association of Governments (SANDAG) publish overdose surveillance data for San Diego County. San Diego-specific features:

  • U.S.-Mexico border adjacency creates some drug-supply dynamics distinct from interior California
  • Military population (largest US Navy homeport) has specific overdose patterns tracked partially through VA and Tricare data separate from civilian reporting
  • Large homeless population in downtown San Diego and East County creates concentrated overdose mortality in specific geographies

Riverside County

Riverside University Health System and Riverside County Department of Public Health publish overdose data. Riverside features:

  • Coachella Valley (Palm Springs, Indio, Desert Hot Springs) has overdose patterns distinct from western Riverside (Riverside city, Corona, Moreno Valley)
  • High SUD treatment residential concentration in Coachella Valley — The Ranch (flagship), Bella Monte (flagship), Banyan Palm Springs (flagship, Cathedral City), Hacienda Valdez (verified tier)
  • Overdose data integrated with Riverside County Behavioral Health reporting

San Bernardino County

San Bernardino County Department of Public Health publishes overdose data. Features:

  • Largest county by area in SoCal — extensive inland area including Victor Valley, High Desert
  • Overdose mortality patterns track urban concentration in San Bernardino, Fontana, Rancho Cucamonga, Ontario, Victorville
  • Thinner SUD treatment infrastructure than LA or OC (zero flagship facilities per our most recent review) creates treatment-access gaps

Ventura County

Ventura County Public Health publishes county-level overdose data. Features:

  • Smallest of the six SoCal counties by population (approximately 800,000)
  • Overdose patterns track statewide trends without distinctive features
  • Integrated with Ventura County Behavioral Health reporting infrastructure

Fentanyl

The single dominant trend in California overdose mortality since 2019–2020. Illicitly-manufactured fentanyl — manufactured primarily outside the U.S. and trafficked into California — replaced most of the heroin supply in California by 2021–2022. Operational features:

  • Potency: 50–100 times more potent than morphine; small dosing errors produce fatal overdoses
  • Counterfeit pill contamination: fentanyl frequently pressed into counterfeit Percocet, Xanax, Adderall tablets. Users intending to use non-fentanyl substances experience fentanyl overdose.
  • Polydrug involvement: fentanyl increasingly found in methamphetamine, cocaine, and other stimulant supplies — producing overdose deaths in populations not historically at opioid overdose risk

For clinical detail on opioid and fentanyl treatment, see our opioid addiction pillar.

Methamphetamine

California’s second-most-prevalent SUD by mortality. Key features:

  • Stable-to-increasing mortality — California methamphetamine overdose deaths have not shown the rapid fentanyl-era increase but remain substantial
  • Polydrug co-involvement — methamphetamine + fentanyl combinations are increasingly common
  • No FDA-approved medication for methamphetamine use disorder — behavioral treatment (contingency management, CBT) is first-line

Cocaine

California cocaine-related overdose mortality has shown resurgence in recent years, often driven by fentanyl contamination of cocaine supplies. Cocaine-overdose-only deaths (without fentanyl) represent a smaller share than combined-substance deaths.

Not technically “overdose” in toxicology terminology but worth noting: California alcohol-related mortality (including alcoholic liver disease, alcohol-related injury, and acute alcohol poisoning) runs at rates that substantially exceed drug-overdose mortality. See our alcohol addiction pillar for context.

Demographic patterns

Racial disparities

California overdose mortality is not distributed equitably across racial and ethnic groups:

  • Black Californians experience overdose mortality at rates that exceed the state-wide average per CDPH published analyses. The disparity has widened in the fentanyl era.
  • American Indian / Alaska Native Californians — populations show elevated overdose mortality rates
  • Latino/Hispanic Californians — rates vary by specific subpopulation; overall close to state average
  • Asian Americans and Pacific Islanders — historically lower overdose rates, though the heterogeneity within API populations means subgroup-specific data is important
  • White Californians — substantial absolute numbers given population size; rates are at or above state average

Disparity analysis requires careful attention to comparison bases. Per-capita rates, absolute numbers, and trends over time each tell different stories. The CDPH dashboard permits disaggregation by race/ethnicity; detailed analysis typically comes from CDPH research publications and LA DPH epidemiology reports.

Age patterns

Overdose mortality concentrates in the 25–55 age range. Young adult (18–24) overdose mortality has increased substantially in the fentanyl era, driven partly by counterfeit pill contamination affecting users who would not historically be at high opioid overdose risk. Older adults (65+) show lower absolute overdose rates but are a growing concern given benzodiazepine and opioid co-use patterns.

Gender

Male overdose deaths exceed female deaths by approximately 3:1 statewide, consistent with national patterns. Women’s overdose rates have increased in recent years though remain substantially below men’s rates.

Reporting lag and data caveats

Overdose mortality data is subject to inherent reporting lag:

  • Provisional data is typically published 6–12 months after the reporting year
  • Final data follows another 6–12 months, after toxicology testing, autopsy reports, and death certificate coding complete
  • Revisions are common as data finalizes — provisional figures can shift meaningfully (5–15% in some measures) before finalizing

This means:

  • 2023 data is mostly finalized at this review
  • 2024 data is provisional; will finalize through 2025–2026
  • 2025 data is not yet published in most measures

Readers seeking current data should check the source dashboards directly rather than relying on this page’s 2023-anchored framing. The CDPH Overdose Surveillance Dashboard updates regularly; LA DPH overdose dashboard updates on a similar cadence.

Policy responses tied to the statistics

Naloxone (Narcan) expansion

California has extensively expanded naloxone availability in response to overdose mortality:

  • Statewide pharmacy access under AB 1535 and subsequent standing order — Narcan available without prescription at every California pharmacy
  • Free distribution through county public health, community organizations, and harm reduction programs
  • Good Samaritan protections — California law protects both witnesses who call 911 for overdose and individuals administering Narcan

For detailed Narcan access, see our opioid addiction pillar.

Fentanyl test strip legalization

California legalized fentanyl test strips as a harm-reduction tool through AB-701 (Quirk-Silva, 2023), effective 2024. Test strips allow detection of fentanyl contamination in drug samples before use, enabling safer practices. Prior to AB-701, fentanyl test strips were classified as drug paraphernalia under California law.

Editorial note: multiple bills addressing fentanyl test strip legalization moved through the California legislature in 2022–2023; specific bill number should be verified against current leginfo.legislature.ca.gov records if precision matters. AB-701 is my understanding of the final legalizing bill.

DMC-ODS expansion

California’s Drug Medi-Cal Organized Delivery System has expanded substantially during the overdose crisis. All six SoCal counties participate. The system provides zero-out-of-pocket SUD treatment access for Medi-Cal-eligible Californians — an important policy response to treatment-access gaps.

CalAIM behavioral health integration

California’s CalAIM initiative is progressively integrating behavioral health services (mental health + SUD) under Medi-Cal managed care. Implementation is ongoing through 2024–2026 with specific impacts on SUD treatment access still developing.

Safe consumption debates

California has debated authorization of supervised consumption sites — facilities where drug users can use substances under medical supervision with overdose-reversal available. Legislation has passed and been vetoed at multiple points; the policy debate continues.

Contingency management for stimulant use disorder

California’s DHCS has operationalized contingency management for stimulant use disorder under DMC-ODS — a major policy response to the methamphetamine overdose dimension of the crisis.

What the statistics don’t tell us

Overdose mortality data captures a specific, measurable endpoint. It does not capture:

  • Non-fatal overdoses — emergency department visits, community-witnessed overdoses, naloxone reversals
  • Substance use disorder prevalence — the population of people with clinical SUD far exceeds those who overdose
  • Treatment access and utilization — how many SUD-affected Californians are engaging with treatment
  • Quality of available treatment — outcomes data on California’s SUD treatment system
  • Social and economic harms — housing, employment, family, and community-level impacts

A complete picture of California’s SUD landscape requires multiple data sources beyond overdose mortality. Other useful sources include:

  • SAMHSA’s National Survey on Drug Use and Health
  • Healthcare Cost and Utilization Project state inpatient databases
  • California Office of Statewide Health Planning and Development data
  • Academic research publications from UC system public health schools

Overdose mortality data tells us the scale of the crisis; connecting to effective treatment is the response. Our editorial team can help identify treatment pathways in any SoCal county, understand Medi-Cal eligibility, and navigate insurance for commercial coverage. We do not accept referral fees. Calls are informational.

Contact our editorial team →

Need help now? Call (310) 596-1751 for editorial guidance. For immediate overdose crisis, call 911. For non-emergency crisis support, dial 988 (Suicide & Crisis Lifeline).

Naloxone (Narcan) is available without prescription at every California pharmacy. Free community distribution is available through county public health and harm-reduction organizations.

Last reviewed: 2026-04-23. Overdose statistics reflect CDPH Overdose Surveillance Dashboard and county-level public health data available at review. Specific figures are the most-recent-available published data and may update as underlying records finalize. This page is editorial content summarizing published surveillance data, not primary epidemiological research.

Looking for treatment options in your area? We can help point you in the right direction. (310) 596-1751 — or request a callback.